Research published in Frontiers in Pediatrics provides clinical evidence that Evivo resolves gut dysbiosis in preterm infants. In an observational cohort study, infants born at less than 1500g and/or 34 weeks corrected gestational age were fed Evivo per hospital feeding protocol. Infants born at greater than 1500g and/or 34 weeks cga were not fed a probiotic. Despite the increased risk associated with extreme prematurity and lower birth weight, preterm infants in the Evivo-fed cohort had:
*Based on TNFa quantification
Only Evivo contains the essential beneficial bacteria, activated B. infantis EVC001. This proprietary strain is the first and only infant probiotic clinically proven to improve the biochemistry of the infant gut, reducing potential gut pathogens and improving human milk utilization. Only Evivo is shown to resolve gut dysbiosis, create a protective environment in the infant gut, and decrease enteric inflammation in infants.
Resolve Gut Dysbiosis and Improve Health Outcomes in NICU Infants
New research shows significant improvement in gut dysbiosis and enteric inflammation in neonates fed Evivo
REQUEST A MEETING
Get the latest updates.
Because Evivo contains the live culture, B, infantis EVC001, shipping conditions are important to ensure your baby receives the freshest product possible. Shipping is $35 Flat Rate Overnight within the contiguous US to ensure your order is delivered as quickly and reliably as possible. Orders shipped to Alaska, Hawaii, Puerto Rico, as well as international shipments, are based on weight and destination.
Orders placed Monday through Thursday before 11:30 am PST ship the same day.
See our FAQs for more information about Orders, Shipping, & Evivo's Return Policy.
Fast. Free Shipping. Learn More.
Notify me when available